SLNSW-A multicenter phase I study of inebilizumab, a hu...-TN_cdi_proquest_journals_2197694819

A multicenter phase I study of inebilizumab, a humanized anti-CD19 monoclonal antibody, in Japanese patients with relapsed or refractory B-cell lymphoma and multiple myeloma

Full title: A multicenter phase I study of inebilizumab, a humanized anti-CD19 monoclonal antibody, in Japanese patients with relapsed or refractory B-cell lymphoma and multiple myeloma

Author/creator: Ohmachi, Ken, Ogura, Michinori, Suehiro, Youko, Ando, Kiyoshi, Uchida, Toshiki, Choi, Ilseung, Ogawa, Yoshiaki, Kobayashi, Miki, Fukino, Koichi, Yokoi, Yuki, Okamura, Jun.

Call Numbers:

Record Identifier: TN_cdi_proquest_journals_2197694819

Language: English

Formats: Articles

Publishers: Tokyo: Springer Japan

Permalink: https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2197694819

Articles

Articles

Export this record

Export selected records

  • Export to excel
  • Permalink

    • Export record to excel

    File type to download

    Beta version

    Record title

    A multicenter phase I study of inebilizumab, a humanized anti-CD19 monoclonal antibody, in Japanese patients with relapsed or refractory B-cell lymphoma and multiple myeloma

    Record identifier

    TN_cdi_proquest_journals_2197694819

    Record permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2197694819

    Share

    A multicenter phase I study of inebilizumab, a humanized anti-CD19 monoclonal antibody, in Japanese patients with relapsed or refractory B-cell lymphoma and multiple myeloma

    ACCESS
    https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2197694819

    A multicenter phase I study of inebilizumab, a humanized anti-CD19 monoclonal antibody, in Japanese patients with relapsed or refractory B-cell lymphoma and multiple myeloma

    Full title

    A multicenter phase I study of inebilizumab, a humanized anti-CD19 monoclonal antibody, in Japanese patients with relapsed or refractory B-cell lymphoma and multiple myeloma

    Author / Creator

    Ohmachi, Ken ; Ogura, Michinori ; Suehiro, Youko ; Ando, Kiyoshi ; Uchida, Toshiki ; Choi, Ilseung ; Ogawa, Yoshiaki ; Kobayashi, Miki ; Fukino, Koichi ; Yokoi, Yuki ; Okamura, Jun

    Publisher

    Tokyo: Springer Japan

    Journal title

    International journal of hematology, 2019, Vol.109 (6), p.657-664

    Record Identifier

    TN_cdi_proquest_journals_2197694819

    Language

    English

    Formats

    Articles

    Publication information

    Publisher

    Subjects

    Subjects and topics

    Adult Aged Aged, 80 and over Antibodies, Monoclonal, Humanized - administration & dosage Antibodies, Monoclonal, Humanized - adverse effects Antibodies, Monoclonal, Humanized - pharmacokinetics Anticancer properties Antigens, CD19 - immunology Antitumor agents Asian Continental Ancestry Group B-cell lymphoma CD19 antigen Chronic lymphocytic leukemia Dosage Female Hematology Hematopoietic stem cells Humans Infusions, Intravenous Leukemia Leukopenia Lymphatic leukemia Lymphocytes B Lymphoma Lymphoma, B-Cell - drug therapy Lymphomas Male Medicine Medicine & Public Health Middle Aged Monoclonal antibodies Multiple myeloma Multiple Myeloma - drug therapy Neutropenia Oncology Original Article Patients Pharmacokinetics Pharmacology Recurrence Stem cell transplantation Stem cells Toxicity Transplantation Treatment Outcome

    More information

    — SCOPE AND CONTENTS

    Contents

    — ALTERNATIVE TITLES

    Full title

    — AUTHORS, ARTISTS AND CONTRIBUTORS

    Author / Creator

    Identifiers

    — PRIMARY IDENTIFIERS

    Record Identifier

    TN_cdi_proquest_journals_2197694819

    Permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2197694819

    — OTHER IDENTIFIERS

    ISSN

    E-ISSN

    DOI

    How to access this item

    Online

    1 item

    How to access?

    Login with a Library card

    Full text available >

    About resource >

    View in old catalogue

    Connecting people and collections